8-K: Atomera Reports Q3 2024 Results, Highlights Collaboration with Sandia National Labs

Atomera announced its Q3 2024 financial results, showcasing a collaboration with Sandia National Laboratories and progress in customer engagements.

Summary

• Atomera reported a net loss of $4.6 million, or $0.17 per share, for the third quarter of 2024, compared to a net loss of $5.0 million, or $0.20 per share, in the same quarter of 2023.
• Adjusted EBITDA for Q3 2024 was a loss of $3.9 million, compared to a loss of $4.3 million in Q3 2023.
• The company's cash, cash equivalents, and short-term investments totaled $17.3 million as of September 30, 2024, down from $19.5 million at the end of 2023.
• Atomera is collaborating with Sandia National Laboratories' CINT to validate its MST technology for GaN manufacturing.
• The company is working with 20 customers on 26 engagements, including at least 10 of the top 20 semiconductor manufacturers.
• Atomera's MST technology is focused on enhancing transistor performance in the $600 billion semiconductor market.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to improved financial metrics and a significant collaboration, but tempered by the company's early stage and ongoing losses.

Positives

• The net loss decreased to $4.6 million in Q3 2024 from $5.0 million in Q3 2023.
• Adjusted EBITDA improved to a loss of $3.9 million in Q3 2024 from a loss of $4.3 million in Q3 2023.
• Atomera has a strong customer pipeline with 20 customers and 26 engagements.
• The collaboration with Sandia National Laboratories' CINT validates MST's potential in GaN manufacturing.
• Atomera's technology targets a large $600 billion semiconductor market.

Negatives

• The company reported a net loss of $4.6 million in Q3 2024.
• Cash reserves decreased to $17.3 million as of September 30, 2024, from $19.5 million at the end of 2023.
• Revenue remains low at $22,000 for the quarter.

Risks

• Atomera is an early-stage company with minimal revenue to date.
• The company's success depends on the adoption of its MST technology by customers.
• There is a risk that customers may not proceed with qualification or commercialization of MST.
• Atomera needs to raise sufficient capital to continue development and commercialization.
• The company faces risks related to protecting its proprietary technology.

Future Outlook

Atomera is optimistic about accelerating engagements in other segments, which they believe will lead to the announcement of licenses and JDAs with more customers in the near term.

Management Comments

• Our recent collaboration with Sandia National Laboratories CINT highlights the expanding opportunities for Atomera in the power segment of the semiconductor industry to supplement the strong progress we've made with our lead customer in this area, said Scott Bibaud, President and CEO.
• We are optimistic about accelerating engagements in our other segments which we believe will lead to the announcement of licenses and JDAs with more customers in the near term.

Industry Context

Atomera's focus on transistor enhancement technology aligns with the semiconductor industry's ongoing efforts to improve performance and power efficiency. The collaboration with Sandia National Labs highlights the growing interest in advanced materials for power applications.

Comparison to Industry Standards

• Atomera's revenue is very low compared to established semiconductor companies, reflecting its early stage and licensing business model.
• The company's focus on licensing technology is different from companies that manufacture and sell chips, such as Intel, TSMC, or Samsung.
• The collaboration with Sandia National Labs is similar to other research partnerships in the semiconductor industry, such as those between universities and companies like Applied Materials or Lam Research.
• Atomera's adjusted EBITDA loss is typical for a pre-revenue technology company, but it needs to demonstrate revenue growth to achieve profitability.

Stakeholder Impact

• Shareholders may be encouraged by the improved financial results and the collaboration with Sandia National Labs.
• Employees may be motivated by the company's progress and future prospects.
• Customers may be interested in the potential benefits of MST technology.
• Suppliers may see potential opportunities for future business.

Next Steps

• Atomera will continue to work with its 20 customers on 26 engagements.
• The company will focus on accelerating engagements in other segments to secure more licenses and JDAs.
• Atomera will continue to validate MST technology through its collaboration with Sandia National Laboratories.

Key Dates

Keywords

MST, semiconductor, technology licensing, GaN, transistor, EBITDA, Atomera, financial results, Sandia National Laboratories, Mears Silicon Technology